AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0149
0.00 (0.00%)
Jul 26, 2024, 1:57 PM EDT - Market closed
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $4.34 million as of July 26, 2024. Its market cap has decreased by -37.70% in one year.
Market Cap
4.34M
Enterprise Value
10.12M
1-Year Change
-37.70%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since July 26, 2019, AXIM Biotechnologies's market cap has decreased from $48.11M to $4.34M, a decrease of -90.97%. That is a compound annual growth rate of -38.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.45M | -24.38% |
| Dec 29, 2023 | 4.56M | -14.40% |
| Dec 30, 2022 | 5.33M | -91.63% |
| Dec 31, 2021 | 63.72M | 16.93% |
| Dec 31, 2020 | 54.50M | 98.93% |
| Dec 31, 2019 | 27.39M | -43.05% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 771.91B |
| Novo Nordisk | 578.41B |
| UnitedHealth Group | 528.45B |
| Johnson & Johnson | 388.41B |
| AbbVie | 328.56B |
| Merck & Co. | 318.25B |
| AstraZeneca | 244.42B |
| Thermo Fisher | 232.84B |